Guardant Health Inc (GH)

R&D Expense Growth

6.04%

Quarterly · Period ending:

GH logo

GH R&D Expense Growth

Latest reported6.04%
GH Quarterly R&D Growth (QoQ) (0.00% → 6.04%)
High-resolution chart · PNG

GH r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Guardant Health Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
6.0359%
-7.3537%
9.2344%
2.868%
-1.211%
-5.3687%
7.1438%
5.0588%
-0.8353%
-6.7374%
-4.2567%
3.8646%
-2.9733%
-12.6199%
6.5599%
17.0405%
4.5232%
11.9637%
2.8929%
11.3678%
14.8015%
37.7985%
11.1381%
-0.2038%
-1.883%
43.057%
5.3156%
25.7884%
19.7107%
-2.0178%
16.8315%
23.3599%
39.9637%
1.6626%
12.0618%
21.272%
11.8914%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.